Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Thyroid Hormone Receptor Interactor 11 (TRIP11) (AA 159-365) antibody

TRIP11 Reactivity: Human WB, IF Host: Mouse Monoclonal 15-GMAP unconjugated
Catalog No. ABIN968639
  • Target See all Thyroid Hormone Receptor Interactor 11 (TRIP11) Antibodies
    Thyroid Hormone Receptor Interactor 11 (TRIP11)
    Binding Specificity
    • 1
    • 1
    • 1
    AA 159-365
    Reactivity
    Human
    Host
    • 10
    • 1
    Mouse
    Clonality
    • 10
    • 1
    Monoclonal
    Conjugate
    • 4
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Un-conjugated
    Application
    • 3
    • 3
    • 1
    • 1
    • 1
    Western Blotting (WB), Immunofluorescence (IF)
    Characteristics
    1. Since applications vary, each investigator should titrate the reagent to obtain optimal results.
    2. Please refer to us for technical protocols.
    3. Caution: Sodium azide yields highly toxic hydrazoic acid under acidic conditions. Dilute azide compounds in running water before discarding to avoid accumulation of potentially explosive deposits in plumbing.
    4. Source of all serum proteins is from USDA inspected abattoirs located in the United States.
    Purification
    The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography.
    Immunogen
    Human GMAP-210 aa. 159-365
    Clone
    15-GMAP
    Isotype
    IgG1
    Top Product
    Discover our top product TRIP11 Primary Antibody
  • Comment

    Related Products: ABIN968537, ABIN967389

    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    250 μg/mL
    Buffer
    Aqueous buffered solution containing BSA, glycerol, and ≤0.09 % sodium azide.
    Preservative
    Sodium azide
    Precaution of Use
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Storage
    -20 °C
    Storage Comment
    Store undiluted at -20° C.
  • Chen, Chen, Chen, Sharp, Lee: "Thyroid hormone, T3-dependent phosphorylation and translocation of Trip230 from the Golgi complex to the nucleus." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 96, Issue 8, pp. 4443-8, (1999) (PubMed).

    Infante, Ramos-Morales, Fedriani, Bornens, Rios: "GMAP-210, A cis-Golgi network-associated protein, is a minus end microtubule-binding protein." in: The Journal of cell biology, Vol. 145, Issue 1, pp. 83-98, (1999) (PubMed).

    Chang, Chen, Chen, Chou, Chen, Ma, Yang-Feng, Leng, Tsai, OMalley, Lee: "A thyroid hormone receptor coactivator negatively regulated by the retinoblastoma protein." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 94, Issue 17, pp. 9040-5, (1997) (PubMed).

  • Target
    Thyroid Hormone Receptor Interactor 11 (TRIP11)
    Alternative Name
    GMAP-210 (TRIP11 Products)
    Synonyms
    ACG1A antibody, CEV14 antibody, GMAP-210 antibody, TRIP-11 antibody, TRIP230 antibody, cb423 antibody, sb:cb423 antibody, sb:cb721 antibody, wu:fb71d07 antibody, MGC79667 antibody, 2610511G22Rik antibody, 3110031G15Rik antibody, 6030460N08Rik antibody, AI450776 antibody, thyroid hormone receptor interactor 11 antibody, thyroid hormone receptor interactor 11 L homeolog antibody, TRIP11 antibody, trip11 antibody, trip11.L antibody, Trip11 antibody
    Background
    Trip230 was identified as a protein that interacts with retinoblastoma protein (Rb) and the thyroid hormone receptor (TR). The structure of Trip230 includes five coiled-coil segments separated by non-helical linkers, N-terminal and C-terminal leucine zipper domains, and multiple phosphorylation sites. Trip230 is ubiquitously expressed and localized to the Golgi. During cell cycle progression, a significant portion of Trip230 translocates to the nucleus. In addition, activation of TR with thyroid hormone (T3) leads to phosphorylation of Trip230, as well as Trip230 translocation from the Golgi to the nucleus. Interestingly, Trip230 has also been identified as a Golgi microtubule-associated protein of 210 kDa (GMAP-210). In vitro , GMAP-210 can bind to the minus end of alpha-tubulin and gamma-tubulin via its C-terminal region, while the N-terminal region is involved in Golgi binding. Overexpression of GMAP-210 leads to enlargement of the Golgi apparatus and alterations in the microtubule cytoskeleton. Thus, GMAP-210/Trip230 is thought to function both as a TR coactivator and as a microtubule-binding protein that anchors the Golgi to the microtubule cytoskeleton.
    Synonyms: Trip230
    Molecular Weight
    210 kDa
You are here:
Support